Maslah, N., Rety, S., Bonnamy, M., Aguinaga, L., Huynh, T., Parietti, V., . . . Cassinat, B. (2024). Niclosamide combined to Azacitidine to target TP53-mutated MDS/AML cells. Leukemia, 38(7), 1630. https://doi.org/10.1038/s41375-024-02281-z
Chicago-referens (17:e uppl.)Maslah, Nabih, Salome Rety, Melina Bonnamy, Lorea Aguinaga, Tony Huynh, Veronique Parietti, Stephane Giraudier, Pierre Fenaux, och Bruno Cassinat. "Niclosamide Combined to Azacitidine to Target TP53-mutated MDS/AML Cells." Leukemia 38, no. 7 (2024): 1630. https://doi.org/10.1038/s41375-024-02281-z.
MLA-referens (9:e uppl.)Maslah, Nabih, et al. "Niclosamide Combined to Azacitidine to Target TP53-mutated MDS/AML Cells." Leukemia, vol. 38, no. 7, 2024, p. 1630, https://doi.org/10.1038/s41375-024-02281-z.
